| Literature DB >> 31114641 |
Jordan Sack1, Nilofar Najafian1, Angela DeLisle2, Simona Jakab3.
Abstract
BACKGROUND: Patients with cirrhosis deemed ineligible for liver transplantation are usually followed in general hepatology or gastroenterology clinics, with the hope of re-evaluation once they meet the appropriate criteria. Specific strategies to achieve liver transplant eligibility for these patients have not been studied. AIM: To assess clinical and sociodemographic factors associated with future liver transplant eligibility among patients initially considered ineligible.Entities:
Keywords: Cirrhosis; Family; Support; Transitional clinic; Transplant listing
Year: 2019 PMID: 31114641 PMCID: PMC6504857 DOI: 10.4254/wjh.v11.i4.370
Source DB: PubMed Journal: World J Hepatol
Figure 1Number of patients who met study criteria, who showed to the first transitional care liver clinic (TCLC) appointment, and who became transplant eligible at 1 year.
Characteristics of overall patient population
| Mean (range) | 51.4 (26-69) |
| Male | 45 (65.2%) |
| Caucasian | 44 (63.8%) |
| Hispanic | 12 (17.4%) |
| African American | 11 (15.9%) |
| Other | 2 (2.9%) |
| Medicaid | 38 (55.1%) |
| Medicare | 13 (18.8%) |
| Private | 14 (20.3%) |
| Uninsured | 4 (5.8%) |
| 2 (2.9%) | |
| 63 (91.3%) | |
| Married | 27 (39.1%) |
| Single | 42 (60.9%) |
| EtOH | 39 (56.5%) |
| EtOH/HCV | 15 (21.7%) |
| HCV | 7 (10.1%) |
| NASH | 4 (5.8%) |
| PBC | 1 (1.4%) |
| NASH/EtOH | 1 (1.4%) |
| AIH | 1 (1.4%) |
| HBV | 1 (1.4%) |
| Other | 0 (0%) |
| 63 (91.3%) | |
| Ascites | 54 (78.3%) |
| Hepatic encephalopathy | 38 (55.1%) |
| Variceal hemorrhage | 20 (29.0%) |
| A | 9 (13.0%) |
| B | 34 (49.3%) |
| C | 26 (37.7%) |
| 15.0 (6-30) | |
| 40 (58.0%) | |
| 9 (13.0%) | |
| 44 (63.8%) | |
| 25 (36.2%) | |
| 19 (27.5%) | |
| 20 (29.0%) |
EtOH: Alcohol; HCV: Hepatitis C virus; PBC: Primary biliary cholangitis; NASH: Non-alcoholic steatohepatitis; AIH: Autoimmune hepatitis; PSC: Primary sclerosing cholangitis; HBV: Hepatitis B virus; TCLC: Transitional care liver clinic.
Characteristics of patients by show and no-show to the first transitional care liver clinic visit
| Mean (range) | 51.8 (26-69) | 50.6 (30-68) | 0.63 |
| Male | 31 (67.4%) | 14 (60.9%) | 0.59 |
| Caucasian | 32 (69.6%) | 12 (52.2%) | 0.16 |
| Hispanic | 6 (13.0%) | 6 (26.1%) | 0.18 |
| African American | 6 (13.0%) | 5 (21.7%) | 0.35 |
| Other | 2 (4.3%) | 0 (0%) | 0.55 |
| Medicaid | 22 (47.8%) | 16 (69.6%) | 0.09 |
| Medicare | 10 (21.7%) | 3 (13.0%) | 0.38 |
| Private | 11 (23.9%) | 3 (13.0%) | 0.29 |
| Uninsured | 3 (6.5%) | 1 (4.3%) | 0.72 |
| 1 (2.2%) | 1 (4.3%) | 0.61 | |
| 43 (93.5%) | 20 (87.0%) | 0.36 | |
| Married | 19 (41.3%) | 8 (34.8%) | 0.60 |
| Single | 27 (58.7%) | 15 (65.2%) | 0.60 |
| EtOH | 28 (60.9%) | 11 (47.8%) | 0.30 |
| EtOH/HCV | 11 (23.9%) | 4 (17.4%) | 0.54 |
| HCV | 3 (6.5%) | 4 (17.4%) | 0.16 |
| NASH | 2 (4.3%) | 2 (8.9%) | 0.47 |
| PBC | 1 (2.2%) | 0 (0%) | 1 |
| NASH/EtOH | 1 (2.2%) | 0 (0%) | 1 |
| AIH | 0 (0%) | 1 (4.3%) | 0.33 |
| HBV | 0 (0%) | 1 (4.3%) | 0.33 |
| Other | 0 (0%) | 0 (0%) | 1 |
| 43 (93.5%) | 20 (87.0%) | 0.36 | |
| Ascites | 36 (78.2%) | 18 (78.3%) | 1 |
| Hepatic Encephalopathy | 27 (58.7%) | 11 (47.8%) | 0.39 |
| Variceal hemorrhage | 13 (28.3%) | 7 (30.4%) | 0.85 |
| A | 5 (10.9%) | 4 (17.4%) | 0.45 |
| B | 24 (52.2%) | 10 (43.5%) | 0.50 |
| C | 17 (37.0%) | 9 (39.1%) | 0.86 |
| 15.3 (6–30) | 14.4 (7-26) | 0.54 | |
| 27 (58.7%) | 13 (56.5%) | 0.86 | |
| 5 (10.9%) | 4 (17.4%) | 0.45 | |
| 29 (63.0%) | 15 (65.2%) | 0.86 | |
| 16 (34.8%) | 9 (39.1%) | 0.72 | |
| 19 (41.3%) | 0 (0.0%) | 0.0001 | |
| 13 (28.3%) | 7 (30.4%) | 0.85 |
EtOH: Alcohol; HCV: Hepatitis C virus; PBC: Primary biliary cholangitis; NASH: Non-alcoholic steatohepatitis; AIH: Autoimmune hepatitis; PSC: Primary sclerosing cholangitis; HBV: Hepatitis B virus; TCLC: Transitional care liver clinic.
Characteristics of patients that showed to the first transitional care liver clinic visit by transplant eligibility at 1 yr
| Mean (range) | 51.9 (26-69) | 51.8 (34-69) | 0.98 |
| Male | 5 (71.4%) | 26 (66.7%) | 0.80 |
| Caucasian | 7 (100.0%) | 25 (64.1%) | 0.08 |
| Hispanic | 0 (0.0%) | 6 (15.4%) | 0.57 |
| African American | 0 (0.0%) | 6 (15.4%) | 0.57 |
| Other | 0 (0.0%) | 2 (5.1%) | 1 |
| Medicaid | 1 (14.3%) | 18 (46.2%) | 0.11 |
| Medicare | 2 (28.6%) | 9 (23.1%) | 0.75 |
| Private | 3 (42.9%) | 9 (23.1%) | 0.27 |
| Uninsured | 1 (14.3%) | 3 (7.7%) | 0.57 |
| 0 (0.0%) | 1 (2.6%) | 1 | |
| 7 (100.0%) | 36 (92.3%) | 1 | |
| Married | 3 (42.9%) | 16 (41.0%) | 0.93 |
| Single | 4 (57.1%) | 23 (59.0%) | 0.93 |
| EtOH | 6 (85.7%) | 22 (56.4%) | 0.14 |
| EtOH/HCV | 0 (0.0%) | 11 (28.2%) | 0.17 |
| HCV | 1 (14.3%) | 2 (5.1%) | 0.37 |
| NASH | 0 (0.0%) | 2 (5.1%) | 1 |
| PBC | 0 (0.0%) | 1 (2.6%) | 1 |
| NASH/EtOH | 0 (0.0%) | 1 (2.6%) | 1 |
| Other | 0 (0%) | 0 (0%) | 1 |
| 7 (100.0%) | 36 (92.3%) | 1 | |
| Ascites | 6 (85.7%) | 30 (76.9%) | 0.60 |
| Hepatic Encephalopathy | 4 (57.1%) | 23 (59.0%) | 0.93 |
| Variceal hemorrhage | 1 (14.3%) | 12 (27.3%) | 0.79 |
| A | 1 (14.1%) | 4 (10.3%) | 0.75 |
| B | 5 (71.4%) | 19 (48.7%) | 0.27 |
| C | 1 (14.1%) | 16 (41.0%) | 0.18 |
| 13.7 (10-20) | 15.6 (6-30) | 0.44 | |
| 2 (28.6%) | 25 (64.1%) | 0.08 | |
| 0 (0.0%) | 5 (12.8%) | 1 | |
| 5 (71.4%) | 24 (61.5%) | 0.62 | |
| 3 (42.9%) | 13 (33.3%) | 0.63 | |
| 6 (85.7%) | 13 (33.3%) | 0.01 | |
| 0 (0.0%) | 13 (33.3%) | 0.17 |
EtOH: Alcohol; HCV: Hepatitis C virus; PBC: Primary biliary cholangitis; NASH: Non-alcoholic steatohepatitis; AIH: Autoimmune hepatitis; PSC: Primary sclerosing cholangitis; HBV: Hepatitis B virus; TCLC: Transitional care liver clinic.